There has been controversy around aducanumab, which targets the cause rather than the symptoms.
Related Articles
-
What does progress mean to you?
What do we mean when we talk about progress? In general terms, to make progress means to move toward...
-
Evolving to a more equitable AI
The pandemic that has raged across the globe over the past year has shone a cold, hard light on...
-
Vaccine waitlist Dr. B collected data from millions. But how many did it help?
The company has continued to promote the idea of a nationwide service, with online posts claiming the service “is...
-
Accelerating AI innovation through application modernization
Yet realizing measurable business value from AI-powered applications requires a new game plan. Legacy application architectures simply aren’t capable...
-
Letter-writing staved off lockdown loneliness. Now it’s getting out the vote.
It blew up—so much so that Cochran had to create Google sheets and forms to help match up writers....
Recent Comments